drugset / Trial / NCT00798148
131I-MIBG With Myeloablative Chemotherapy and Autologous Stem Cell Transplantation for the Treatment of High-risk Neuroblastoma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This trial is studying how well iodine I 131 metaiodobenzylguanidine together with combination chemotherapy works in treating patients who are undergoing an autologous peripheral stem cell for high risk or relapsed neuroblastoma.
Timeline
- Start
- 2008-09
- Primary completion
- 2012-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 131I-MIBG | Protein / enzyme biologic | 12 unknown | — |
| Subject | Carboplatin | Small molecule | 1500 mg/m2 | — |
| Subject | Etoposide | Small molecule | 1200 mg/m2 | — |
| Subject | Melphalan | Small molecule | 210 mg/m2 | — |